Flavobacterium-meningosepticum Septicemia And Peritonitis Complicating Capd
bacteremia; infection; multivorum; susceptibility; Urology & Nephrology
Marnejon T; Watanakunakorn C
Clinical Nephrology
1992
1992-09
Journal Article or Conference Abstract Publication
n/a
The Clinical Relevance Of Penicillin-resistant Streptococcus Pneumoniae: A New Perspective
antibiotic-resistance; bacteremia; community-acquired pneumonia; epidemiology; Immunology; Infectious Diseases; metaanalysis; Microbiology; molecular; mortality; outcomes; pneumococcal pneumonia; susceptibility; united-states
File T M; Tan J S; Boex J R
Clinical Infectious Diseases
2006
2006-03
Journal Article or Conference Abstract Publication
<a href="http://doi.org/10.1086/500142" target="_blank" rel="noreferrer noopener">10.1086/500142</a>
Cancer risk assessment: Examining the family physician's role
colonoscopy; colorectal-cancer; General & Internal Medicine; history; individuals; knowledge; ovarian-cancer; racial-differences; screening practices; surveillance; susceptibility
Background: Cancer risk assessment begins in the primary care clinician's office. Essential components of that process include: 1) documentation of personal and family cancer information; 2) identification of families at increased risk for cancer; 3) modification of cancer screening recommendations according to degree of risk; 4) referral of high-risk individuals to cancer genetics clinics. The purpose of this study was to examine these 4 components of primary care cancer risk assessment using data abstracted from patient records at an academic family medicine center. Methods: Ambulatory records of 734 patients were reviewed in their entirety for information relevant to cancer risk assessment. Detail of cancer information was categorized as comprehensive, adequate, or inadequate. Patient records were categorized as suggestive of average, moderate, or high genetic risk for cancer. For patients with a family history of colorectal cancer, modification of colon cancer screening to reflect degree of cancer risk was assessed. Finally, the frequency of cancer genetic referral in high-risk individuals was noted. Results: The presence or absence of a family history of cancer was documented in 97.8% of records. There was insufficient information to adequately assess risk in 69.5% of charts. Detail of family cancer documentation was associated with personal history of cancer ( P =.001), patient age ( P =.001), and physician training status ( P =.042), but not with patient or physician gender, duration of care, or completion of a genogram. For persons with a family history of colorectal cancer, compliance with cancer screening individualized to degree of risk was achieved in 50% of patients. Ten patients met criteria for moderate or high genetic risk for cancer. None had been offered cancer genetics consultation. Conclusions: Nearly all records documented the presence or absence of a family history of cancer. However, in those with a positive family history, the detail of information was insufficient to permit risk assessment in over two thirds of individuals; risk-stratified colon cancer screening was not achieved in half of the patients with a family history of colorectal cancer; individuals at moderate or high cancer risk were not identified as such; and those at high risk were not offered cancer genetics referral. In addition to collecting adequate family cancer information, family physicians need to adopt explicit risk assessment criteria to identify, and to optimally care for, those at increased genetic risk for cancer.
Tyler C V; Snyder C W
Journal of the American Board of Family Medicine
2006
2006-09
Journal Article
<a href="http://doi.org/10.3122/jabfm.19.5.468" target="_blank" rel="noreferrer noopener">10.3122/jabfm.19.5.468</a>
Staphylococcus aureus Bacteremia (SAB) With Associated S-aureus Bacteriuria (SABU) as a Predictor of Complications and Mortality
adults; blood-stream infections; complications and mortality; complications from Staphylococcus aureus bacteremia; endocarditis; General & Internal Medicine; management; predictor of; Staphylococcus aureus bacteremia; Staphylococcus aureus bacteriuria; susceptibility; therapy; urinary-tract-infection
BACKGROUND AND OBJECTIVES: Staphylococcus aureus (SA) bacteremia (SAB) is associated with a high rate of complications, most of which are related to hematogenous seeding into deep tissues or prosthetic material. SA bacteriuria (SABU) has been described in association with SAB, but has not been evaluated as a predictor for complicated bacteremia, which was the objective of our study. METHODS (DESIGN, SETTING, AND PATIENTS): We conducted a retrospective study of patients admitted to the hospital with SAB. The 118 patients included in the study were divided in 2 cohorts: a group with SABU and a group without SA in the urine. We followed the 2 cohorts for an average of 8 months and evaluated the differences in complications and mortality. RESULTS: SABU was found in 28 of 118 patients with SAB. Eighteen patients (64%) in this group had complications from the bacteremia, while in the group without SABU only 33% (30/90 patients) had complications (P = 0.004). The SABU group also had more deaths (32% vs. 14%; P = 0.036). CONCLUSIONS: In this population of hospitalized patients with SAB, the presence of SABU was associated with an increased risk of early complications, including septic shock, and with higher mortality. A routine urine culture in search of SABU may be a helpful tool for detection of those patients with SAB who are at increased risk of complications and death. Journal of Hospital Medicine 2010;5:208-211. (C) 2010 Society of Hospital Medicine.
Perez-Jorge E V; Burdette S D; Marked R J; Beam W B
Journal of Hospital Medicine
2010
2010-04
Journal Article
<a href="http://doi.org/10.1002/jhm.623" target="_blank" rel="noreferrer noopener">10.1002/jhm.623</a>
Are New beta-Lactam/beta-Lactamase Inhibitors Viable Carbapenem Sparing Options for Treating Serious Infections Caused by Extended-Spectrum beta-Lactamase-Producing Microorganisms?
Infectious Diseases; Immunology; escherichia-coli; susceptibility; cephalosporins
Kallstrom G
Infectious Diseases in Clinical Practice
2019
2019-05
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
<a href="http://doi.org/10.1097/ipc.0000000000000729" target="_blank" rel="noreferrer noopener">10.1097/ipc.0000000000000729</a>